Iterative Scopes Company
Iterative Scopes delivers tools for physicians and life sciences in colorectal cancer and inflammatory bowel disease space.
Investors
Funding Status:
Early Stage Venture
Industry:
HealthCare Administration
Estimated Revenue:
Less than $1M
Technology:
['BioTech & HealthTech']
Headquarters:
Cambridge, Massachusetts, United States
Total Funding:
19049241
Last Funding Type:
Series A
Investor Type:
For Profit
Employee Number:
101-250
Investors Number:
5
Founded Date:
2017